The Escherichia coli phylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections

APMIS

Volumn 122, Issue 5, 2014, Pages 452-458

  Kõljalg, Siiri ^a   Truusalu, Kai ^a   Stsepetova, Jelena ^a   Pai, Kristiine ^a   Vainumäe, Inga ^a   Sepp, Epp ^a   Mikelsaar, Marika ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Antibiotic resistance; Integron; Phylogenetic group; Recurrence; Urinary tract infection

Indexed keywords

AMPICILLIN; BETA LACTAM; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; ESCHERICHIA COLI; ESCHERICHIA COLI PHYLOGENETIC GROUP B2; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INTEGRON; MALE; MINIMUM INHIBITORY CONCENTRATION; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; PYELONEPHRITIS; RECURRENT DISEASE; RECURRENT INFECTION; RECURRENT URINARY TRACT INFECTION; RELAPSE; URINALYSIS; URINARY TRACT INFECTION;

ANTIBIOTIC RESISTANCE; INTEGRON; PHYLOGENETIC GROUP; RECURRENCE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CEFOTAXIME; CEFUROXIME; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENTAMICINS; HUMANS; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; RECURRENCE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS;

EID: 84899487309     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12167     Document Type: Article

References (37)

1. Levine MM. Escherichia coli infections. N Engl J Med 1985;313:445-7.
2. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000;181:261-72.
3. Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 2007;4:134-63.
4. Moreno E, Johnson JR, Perez T, Prats G, Kuskowski MA, Andreu A. Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect 2009;11:274-80.
5. Nowrouzian FL, Wold AE, Adlerberth I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis 2005;191:1078-83.
6. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999;67:546-53.
7. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 2001;183:78-88.
8. Ho PL, Wong RC, Chow KH, Que TL. Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals. Lett Appl Microbiol 2009;49:627-34.
9. Moreno E, Planells I, Prats G, Planes AM, Moreno G, Andreu A. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia. Diagn Microbiol Infect Dis 2005;53:93-9.
10. Skurnik D, Le Menac'h A, Zurakowski D, Mazel D, Courvalin P, Denamur E, et al. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob Agents Che-mother 2005;49:3062-5.
11. Kawamura-Sato K, Yoshida R, Shibayama K, Ohta M. Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan. Jpn J Infect Dis 2010;63:113-5.
12. Andreson H, Sillakivi T, Peetsalu M, Peetsalu A, Mikelsaar M. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation. Scand J Gastroenterol 2007;42:324-9.
13. Ejrnaes K, Sandvang D, Lundgren B, Ferry S, Holm S, Monsen T, et al. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J Clin Microbiol 2006;44:1776-81.
14. Koljalg S, Truusalu K, Vainumae I, Stsepetova J, Sepp E, Mikelsaar M. Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent urinary tract infections in childhood. J Clin Microbiol 2009;47:99-105.
15. France AM, Kugeler KM, Freeman A, Zalewski CA, Blahna M, Zhang L, et al. Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli. Clin Infect Dis 2005;40:1101-7.
16. Bopp CA, Brenner FW, Wells JG, Strockbin N. Escherichia, Shigella, and Salmonella, In: Murray PR, Baron EJ, editors. Manual of Clinical Microbiology. 7th edn. Washington, DC: ASM Press, 1999: 459-74.
17. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8.
18. Levesque C, Piche L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995;39:185-91.
19. Soto SM, Zuniga S, Ulleryd P, Vila J. Acquisition of a pathogenicity island in an Escherichia coli clinical isolate causing febrile urinary tract infection. Eur J Clin Microbiol Infect Dis 2011;30:1543-50.
20. Bonacorsi S, Houdouin V, Mariani-Kurkdjian P, Mahjoub-Messai F, Bingen E. Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia. J Clin Microbiol 2006;44:1156-8.
21. Park S, Han JY, Kim KS. Risk factors for recurrent urinary tract infection in infants with vesicoureteral reflux during prophylactic treatment: effect of delayed contrast passage on voiding cystourethrogram. Urology 2011;78:170-3.
22. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010;126:1084-91.
23. Zaffanello M, Tardivo S, Cataldi L, Fanos V, Biban P, Malerba G. Genetic susceptibility to renal scar formation after urinary tract infection: a systematic review and meta-analysis of candidate gene polymorphisms. Pediatr Nephrol 2011;26:1017-29.
24. Houdouin V, Bonacorsi S, Mahjoub-Messai F, Mariani-Kurkdjian P, Bidet P, Sebag G, et al. Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalities. Clin Microbiol Infect 2007;13:740-2.
25. Rijavec M, Muller-Premru M, Zakotnik B, Zgur-Bertok D. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J Med Microbiol 2008;57:1329-34.
26. Jantunen ME, Saxen H, Salo E, Siitonen A. Recurrent urinary tract infections in infancy: relapses or reinfections? J Infect Dis 2002;185:375-9.
27. Ejrnaes K, Stegger M, Reisner A, Ferry S, Monsen T, Holm SE, et al. Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence 2011;2:528-37.
28. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010;54:1855-63.
29. Brady PW, Conway PH, Goudie A. Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections. Pediatrics 2010;126:196-203.
30. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. Bacterial persistence as a phenotypic switch. Science 2004;305:1622-5.
31. Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Microbiol 2010;8:207-17.
32. Moreno E, Andreu A, Perez T, Sabate M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect 2006;134:1015-23.
33. Jantunen ME, Saxen H, Lukinmaa S, Ala-Houhala M, Siitonen A. Genomic identity of pyelonephritogenic Escherichia coli isolated from blood, urine and faeces of children with urosepsis. J Med Microbiol 2001;50:650-2.
34. Ramos NL, Dzung DT, Stopsack K, Janko V, Pourshafie MR, Katouli M, et al. Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries. Eur J Clin Microbiol Infect Dis 2011;30:1587-93.
35. Villa L, Carattoli A. Integrons and transposons on the Salmonella enterica serovar typhimurium virulence plasmid. Antimicrob Agents Chemother 2005;49:1194-7.
36. Rijavec M, Starcic Erjavec M, Ambrozic Avgustin J, Reissbrodt R, Fruth A, Krizan-Hergouth V, et al. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr Microbiol 2006;53:158-62.
37. Karkkainen UM, Ikaheimo R, Katila ML, Siitonen A. Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand J Infect Dis 2000;32:495-9.